Clinical trial · Observational
Real-world Clinical Benefit Evaluation in Breast Cancer Patients With Pharmaceutical Interventions for Cancer-related Fatigue
NCT05428527CI-TRIAL-00078514completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This retrospective study is to collect and analyze the data from medical records within the period that breast cancer patient is receiving NHI-covered CRF treatment. This study will evaluate the clinical use, fatigue improvement, and treatment satisfaction of breast cancer patients with CRF treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer-related Fatigue | Breast Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Breast cancer patients with Cancer-related fatigue treatment
- description
- Breast cancer patients who approved to use NHI to pay for Cancer-related fatigue treatment drug
Primary outcomes (1)
- measure
- Fatigue Improvement
- timeFrame
- through study completion, an average of 4 months
Secondary outcomes (8)
- measure
- The Level of Fatigue Clinical Global Impression-Improvement
- timeFrame
- through study completion, an average of 4 months
- measure
- Physician Satisfaction Degree of Overall Clinical Evaluation
- timeFrame
- 1 time, average of 4 months after baseline (at the end of study)
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * breast cancer patients who approved to use NHI to pay for cancer-related fatigue treatment drug Exclusion Criteria: * N/A
References
Publications (0)
Data not yet available
No reference posted for this study.